Bluestar Genomics Closes $70M Series C Funding, Expands Scientific Advisory Board
SAN DIEGO, May 17 (Bernama-BUSINESS WIRE) — Bluestar Genomics, an innovative company leading the development of next-generation epigenomic approaches to early cancer detection, today announced the company had raised $70 million in new equity funding. Led with the increased funding by the current investor, Mattias Westman, founding partner of Prosperity Capital…

